Garth Whiteside

This inventor holds 19 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Sleep Disorders Treatment. Top assignee: Purdue Pharma L.p.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Garth Whiteside. Retrieved from https://idiyas.com/inventor/garth-whiteside

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 40(Granted Patents)

Location History:

Princeton, NJ (US) (2015 - 2018)
Yardley, PA (US) (2017 - 2023)

Company Filing History:

19 out of 547

Purdue Pharma L.p.

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Sleep Disorders

Opioid Treatment

Pharmacodynamic Response

Gastric Emptying

Adverse Effects

Dosage Forms

Treatment Methods

Prevention Strategies

Compositions

Systems

Healthcare Solutions

Pharmaceutical Innovations

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582647 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2026-03-24),

2. 12370191 - Treatment and prevention of sleep disorders (2025-07-29),

3. 12201629 - Method of treatment and dosage forms thereof (2025-01-21),

4. 12171762 - Sleep disorder treatment and prevention (2024-12-24),

5. 11738023 - Treatment and prevention of sleep disorders (2023-08-29),

6. 11576913 - Sleep disorder treatment and prevention (2023-02-14),

7. 10974081 - Treatment and prevention of sleep disorders (2021-04-13),

8. 10398690 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2019-09-03),

9. 10226457 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2019-03-12),

10. 10143696 - Methods and compositions for decreasing gastric emptying (2018-12-04),

11. 9931337 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2018-04-03),

12. 9884059 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2018-02-06),

13. 9872856 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2018-01-23),

14. 9867817 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2018-01-16),

15. 9855262 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2018-01-02),

Title: Garth Whiteside: Innovator in Sleep Disorder Treatments

Introduction

Garth Whiteside, an accomplished inventor based in Yardley, PA, has significantly contributed to the field of pharmacology with 18 patents to his name. His work mainly focuses on treating and preventing sleep disorders, showcasing his dedication to improving the quality of life through innovative medical solutions.

Latest Patents

Among his latest patents, Whiteside has developed methods for treating or preventing sleep disorders by administering specific compounds. These compounds, which include various formulations (Formula (1), (1A), (1B), (1C), (1D), and (1E)), effectively target sleep disorders in animals while minimizing side effects compared to existing treatments. Additionally, he has patented an oral dosage form combining oxycodone and buprenorphine, designed to treat pain more effectively while reducing adverse effects, such as respiratory depression, associated with standard opioid therapies.

Career Highlights

Garth Whiteside is a key player at Purdue Pharma L.P., where he applies his extensive knowledge and expertise in drug formulation and therapeutic applications. His innovations in medication serve to bridge gaps in current treatment options, particularly in managing pain and sleep disorders—conditions affecting countless individuals worldwide.

Collaborations

Throughout his career, Whiteside has collaborated with notable colleagues, including Donald J. Kyle and Michele Hummel. These partnerships have undoubtedly fostered a shared creative environment that enhances the development of effective therapeutic solutions.

Conclusion

Garth Whiteside's contributions to the field of medicine through his patents illustrate his commitment to advancing healthcare solutions. His ongoing work at Purdue Pharma L.P. continues to pave the way for innovative treatments that address the pressing issues of sleep disorders and pain management. As he progresses in his career, Whiteside remains a prominent figure in the quest for medical advancements that improve patient outcomes.

Profile summary based on public USPTO records.